Recently, mutations in GATAD2B were identified in patients with GAND (GATAD2B-associated neurodevelopmental disorder), a NDD characterized by intellectual disability (ID), infantile hypotonia, apraxia of speech, epilepsy. The gene discussed is GATAD2B; the disease is epilepsy.